✦ LIBER ✦

Multicenter Randomized Trial for Stage IIIB/IV Non–Small-Cell Lung Cancer Using Every-3-Week Versus Weekly Paclitaxel/Carboplatin

✍ Scribed by Wolfgang Schuette; Thomas Blankenburg; Wolf Guschall; Ina Dittrich; Michael Schneider; Hans Schweisfurth; Assaad Chemaissani; Christian Schumann; Nikolas Dickgreber; Tabea Appel; Dieter Ukena

Book ID: 119935538
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 512 KB
Volume: 7
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2006.n.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advanced non-small cell lung cancer in e

Advanced non-small cell lung cancer in elderly patients: The standard every 3-weeks versus weekly paclitaxel with carboplatin

✍ El-Shenshawy, Hala Mohamed; Taema, Saleh; El-Zahaf, Eman; El-Beshbeshi, Wafaa; S 📂 Article 📅 2012 🏛 Medknow Publications 🌐 English ⚖ 408 KB

P-251 Randomized phase II trial of weekl

P-251 Randomized phase II trial of weekly carboplatin/paclitaxel (C/P) versus every-3-week C/P in advanced non-small cell lung cancer (NSCLC): A pure schedule trial

✍ Socinski, Mark A.; Hensing, Thomas A.; Escudero, Miluska; Tynan, Maureen; Baggst 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 340 KB

O-217 A randomized phase III trial of ge

O-217 A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) Non-Small Cell Lung Cancer (NSCLC)

✍ Treat, Joe; Chandra, Belani P.; Edelman, Martin; Socinski, Mark; Gonin, R.; Ansa 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 170 KB

O-220 Gemcitabine plus cisplatin versus

O-220 Gemcitabine plus cisplatin versus gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: A phase III randomized trial

✍ Zatloukal, Petr; Petruzelka, Lubos; Zemanova, Milada; Kolek, Vitezslav; Skrickov 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Prolonged oral versus high-dose intraven

Prolonged oral versus high-dose intravenous etoposide in combination with carboplatin for stage IV non-small-cell lung cancer (NSCLC): a randomized trial

✍ Jeremic, Branislav; Shibamoto, Yuta; Milicic, Biljana; Milisavljevic, Slobodan; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Phase II multicenter randomized trial of

Phase II multicenter randomized trial of induction weekly paclitaxel (P) administered in combination with carboplatin (C) followed by weekly maintenance P vs. observation for patients (pts.) with advanced & metastatic non-small cell lung cancer (NSCLC)

✍ Belani, C.P; Barstis, J; Clark, R; Mills, G; Perry, M; Nattam, S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 110 KB